Get Real Time Here
| Open2.870 | Close- |
| Vol / Avg.101.661K / 545.336K | Mkt Cap286.903M |
| Day Range2.730 - 2.870 | 52 Wk Range1.960 - 5.600 |
Humacyte Stock (NASDAQ:HUMA), Quotes and News Summary
Humacyte Stock (NASDAQ: HUMA) stock price, news, charts, stock research, profile.
| Open2.870 | Close- |
| Vol / Avg.101.661K / 545.336K | Mkt Cap286.903M |
| Day Range2.730 - 2.870 | 52 Wk Range1.960 - 5.600 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.250 | -0.250 | 0.0000 | ||||
| REV | 70.000K | 0 | -70.000K |
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.220 | -0.220 | 0.0000 | ||||
| REV | 70.000K | 0 | -70.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-12-11 | HC Wainwright & Co. | Vernon Bernardino | Initiates Coverage On | Buy | Announces | - | 6.00 |
| 2023-11-10 | Piper Sandler | Matt O'Brien | Maintains | NeutralNeutral | Lowers | 3.50 | 3.00 |
| 2023-09-21 | Cantor Fitzgerald | Kristen Kluska | Reiterates | OverweightOverweight | Maintains | - | 7.00 |
| 2023-08-31 | Cantor Fitzgerald | Kristen Kluska | Reiterates | OverweightOverweight | Maintains | - | 6.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| HUMA | Humacyte | -1.07% | 286.9M |
| IMNM | Immunome | 0.26% | 331.2M |
| KALV | KalVista Pharma | -4.78% | 267.3M |
| BLUE | bluebird bio | 5.27% | 329.2M |
| PGEN | Precigen | -3.37% | 283.8M |
How do I buy Humacyte (HUMA) stock?
You can purchase shares of Humacyte (NASDAQ: HUMA) through any online brokerage.
Who are Humacyte's (HUMA) competitors?
Other companies in Humacyte’s space includes: Immunome (NASDAQ:IMNM), KalVista Pharma (NASDAQ:KALV), bluebird bio (NASDAQ:BLUE), Precigen (NASDAQ:PGEN) and Anika Therapeutics (NASDAQ:ANIK).
What is the target price for Humacyte (HUMA) stock?
The latest price target for Humacyte (NASDAQ: HUMA) was reported by HC Wainwright & Co. on Monday, December 11, 2023. The analyst firm set a price target for 6.00 expecting HUMA to rise to within 12 months (a possible 116.61% upside). 9 analyst firms have reported ratings in the last year.
Current Stock Price for Humacyte (HUMA)?
The stock price for Humacyte (NASDAQ: HUMA) is $2.77 last updated Today at December 11, 2023 at 4:00 PM UTC.
Does Humacyte (HUMA) pay a dividend?
There is no dividend information for Humacyte.
When is Humacyte (NASDAQ:HUMA) reporting earnings?
Humacyte’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is Humacyte (HUMA) going to split?
There is no upcoming split for Humacyte.
What sector and industry does Humacyte (HUMA) operate in?
Humacyte is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.